Ziopharm Oncology

-$0.10 (-7.58%) Today
+$0.03 (+2.46%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZIOP and other ETFs, options, and stocks.

About ZIOP

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T.

CEO
Kevin S. Boyle
Employees
106
Headquarters
Boston, Massachusetts
Founded
2003

ZIOP Key Statistics

Market cap
263.70M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.49M
High today
$1.32
Low today
$1.22
Open price
$1.31
Volume
3.19M
52 Week high
$5.95
52 Week low
$1.22

ZIOP Earnings

-$0.63
-$0.42
-$0.21
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 24, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure